Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

Background: The National Institute for Health and Clinical Excellence (NICE) was reviewing its previous guidance on continuous subcutaneous insulin infusion (CSII). The review provided an assessment of evidence which had been published since the previous NICE appraisal (TA 151) in 2007. Objectives:...

Full description

Bibliographic Details
Main Authors:	E Cummins, P Royle, A Snaith, A Greene, L Robertson, L McIntyre, N Waugh
Format:	Article
Language:	English
Published:	NIHR Journals Library 2010-02-01
Series:	Health Technology Assessment
Subjects:	clinical effectiveness continuous subcutaneous insulin infusion diabetes systematic review economic evaluation
Online Access:	https://doi.org/10.3310/hta14110

Similar Items

Continuous subcutaneous insulin infusion versus multiple dose insulin
by: Yashdeep Gupta, et al.
Published: (2014-08-01)

Outcomes for continuous subcutaneous insulin infusion users in young adults from lower socioeconomic backgrounds
by: Alexis M. McKee, et al.
Published: (2021-07-01)

Continuous Subcutaneous Insulin Infusion in Children: A Pilot Study Validating a Protocol to Avoid Hypoglycemia at Initiation
by: Patricia Olivier, et al.
Published: (2017-04-01)

Continuous subcutaneous insulin infusion therapy: effects on quality of life
by: U Scheidegger, et al.
Published: (2007-08-01)

Effects of continuous subcutaneous insulin infusion on the microstructures, mechanical properties and bone mineral compositions of lumbar spines in type 2 diabetic rats
by: Xiaorong Hu, et al.
Published: (2022-05-01)

Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus
by: Takafumi Masuda, et al.
Published: (2022-09-01)

Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis
by: Guo Keyu, et al.
Published: (2022-08-01)

Disordered eating behaviour in adolescents with type 1 diabetes on continuous subcutaneous insulin infusion; relation to body image, depression and glycemic control
by: Nouran Yousef Salah, et al.
Published: (2022-04-01)

Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Pediatric Type 1 Diabetes: A Meta‐Analysis and Prospective Cohort Study
by: Xu Wang, et al.
Published: (2021-03-01)

Continuous Intravenous versus Subcutaneous Administration of Insulin for Glycemic Variability in Acute Ischemic Stroke
by: Du LZ, et al.
Published: (2022-07-01)

A Systematic Review and Meta-Analysis of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections in Type-2 Diabetes
by: Vasiliki Chatziravdeli, et al.
Published: (2023-01-01)

Continuous Intravenous versus Subcutaneous Administration of Insulin for Glycemic Variability in Acute Ischemic Stroke [Corrigendum]
by: Du LZ, et al.
Published: (2022-08-01)

Comparative study of the adverse effects of subcutaneous and intraveneous infusion in patients admitted to neurology ward
by: Simin Jahani, et al.
Published: (2009-10-01)

An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?
by: J. Baker, et al.
Published: (2020-07-01)

Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT
by: Joanne Blair, et al.
Published: (2018-08-01)

Efficacy and safety of SGLT2 inhibitors in individuals with type 1 diabetes under continuous subcutaneous insulin infusion: a real-world study
by: Silva Vania Benido, et al.
Published: (2023-01-01)

Investigation of factors that cause insulin precipitation and/or amyloid formation in insulin formulations
by: Yui Ohno, et al.
Published: (2019-10-01)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
by: Ekaterina Viktorovna Artemova, et al.
Published: (2012-09-01)

The 12 month impact of continuous insulin infusion therapy on glycaemic control in adults with type 1 diabetes, at the Townsville hospital, Queensland - A retrospective study
by: Suji Prabhaharan, et al.
Published: (2019-04-01)

Evaluation of diabetic patients after three month use of continuous subcutaneous insulin infusion, dispensed by a protocolled form at outpatient reference clinic of Taguatinga Regional Hospital
by: Leonardo Garcia Miranda, et al.

Psychosocial aspects of continuous subcutaneous insulin infusion in children with type 1 diabetes in Egypt; a limited resources country perspective
by: Mona Hussein El Samahy, et al.
Published: (2022-06-01)

Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs)
by: Daniel P. Howsmon, et al.
Published: (2017-01-01)

Continuous subcutaneous apomorphine monotherapy in Parkinson’s disease
by: Ewa Papuć, et al.
Published: (2019-03-01)

Insulin/carbohydrates ratio during the first 6‐month therapy with insulin degludec in a paediatric population with type 1 diabetes previously treated with insulin glargine. An observational longitudinal study
by: Stefano Tumini, et al.
Published: (2020-04-01)

A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial
by: Simon Heller, et al.
Published: (2017-04-01)

Insulin pump therapy in type 1 diabetes mellitus: education effectiveness and quality of life
by: Lyudmila Ibragimovna Ibragimova, et al.
Published: (2012-03-01)

Continuous subcutaneous infusion for pain control in dying patients: experiences from a tertiary palliative care center
by: Per Fürst, et al.
Published: (2020-11-01)

Insulin pump therapy would be favored by pregnant women with diabetes
by: Aya Osaki, et al.
Published: (2020-12-01)

Maternal-fetal outcomes of pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections during pregnancy – A Brazilian health care referral center cohort study
by: Juliana Ogassavara, et al.
Published: (2023-07-01)

The 5th International Conference on Advanced Technologies Treatments for Diabetes (ATTD 2012),2012 February 8-11, Barcelona (Spain)
by: Yury Ivanovich Filippov, et al.
Published: (2012-03-01)

Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care
by: Guido Kramer, et al.
Published: (2021-07-01)

Complications of the subcutaneous route in the infusion of medications and solutions in palliative care
by: Natália de Almeida Barbosa Guedes, et al.
Published: (2019-09-01)

Subcutaneous vitamin B12 administration using a portable infusion pump in cobalamin-related remethylation disorders: a gentle and easy to use alternative to intramuscular injections
by: Amelie S. Lotz-Havla, et al.
Published: (2021-05-01)

Effect of Bolus Insulin Administration Followed by a Continuous Insulin Infusion on Diabetic Ketoacidosis Management
by: Hannah D. Brown, et al.
Published: (2018-12-01)

Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson’s disease: Considerations for initiation and maintenance
by: Victor S.C. Fung, et al.
Published: (2024-01-01)

Telemedicine in the Time of the COVID-19 Pandemic: Results from the First Survey among Italian Pediatric Diabetes Centers
by: Gianluca Tornese, et al.
Published: (2021-06-01)

Safety of an ultra-rush subcutaneous immunotherapy using an infusion pump in real-life
by: Silvia Uriarte, et al.
Published: (2018-06-01)

Advances in safe insulin infusions
by: Fred Massoomi, et al.
Published: (2021-07-01)

Effectiveness and safety of flexible therapeutic schemes including first- and secondgeneration basal insulins during a pediatric summer diabetes camp
by: Stefano Tumini, et al.
Published: (2020-04-01)

Insulin Requirements and Carbohydrate to Insulin Ratio in Normal Weight, Overweight, and Obese Women With Type 1 Diabetes Under Pump Treatment During Pregnancy: A Lesson From Old Technologies
by: Camilla Festa, et al.
Published: (2021-02-01)